Najmiatul Masykura

Najmiatul Masykura

Auto-generated profile, based on publicly available information

Najmiatul Masykura

Cancer Diagnostic Research, Stem-cell and Cancer Institute, Jakarta, Indonesia

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in Lung Cancer: Targets and Therapy
Verified
Journal Article
Open access
PDF file
NMNajmiatul Masykura
Najmiatul Masykura
JZJamal Zaini
Jamal Zaini
ESElisna Syahruddin
Elisna Syahruddin
SASita Laksmi Andarini
Sita Laksmi Andarini
AHAchmad Hudoyo
Achmad Hudoyo
AUAhmad Rusdan Handoyo Utomo
Ahmad Rusdan Handoyo Utomo
Background: Indonesia has the highest cigarette consumption in the world. We explored the clinical impact of smoking on the prevalence of EGFR and K-RAS mutations and survival in this prospective study. Methods: 143 treatment naive lung cancer patients were recruited from Persahabatan Hospital, a national tertiary hospital. DNA from cytological specimens had been extracted and genotyped for both EGFR and K-RAS mutations using a combination of PCR high resolution melting, restriction fragment length polymorphism (RFLP) and direct DNA sequencing. Results: EGFR mutation frequency in never smokers (NS) and ever smokers (ES) were 75% and 56% (p = 0.0401), respectively. In this cohort, the overall K-RAS mutation rate was 7%. Neither gender nor smoking history were associated with K-RAS mutation significantly. However, K-RAS transversion mutations were more common in male ES than transition mutations. Smoking history did not affect EGFR and K-RAS mutation frequencies in women. Concurrent EGFR/K-RAS mutation rate was 2.8% (4 of 143 patients). Four out of 91 EGFR mutation positive patients (4.4%) had simultaneous K-RAS mutation. Conclusions: In region where cigarette consumption is prevalent, smoking history affected frequencies of EGFR and K-RAS mutations, mainly in males.